2Cholesterol Treatment Trialists' (CTI~) Collaboration, Baigent C, Blaekwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 2010,376 : 1670-1681.
3Komori T. , Shinkai S.. Chem. Lett. [J], 1992:901-904
5Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines[J].Circulation,2004,110(6):27-239.
6European Association for Cardiovascular Prevention&Rehabilita-tion.ESC/EAS Guidelines for the management of dyslipidaemias:the Task Force for the management of dyslipidaemias of the European Society of Cardiology(ESC)and the European Atherosclerosis Society(EAS)[J].Eur Heart J,2011,32(14):1769-1818.
10Boekholdt SM, Arsenault BJ, Hovingh GK, et al. Levels and Chan- ges of HDL cholesterol and apolipoprotein AI in relation to risk of Cardiovascular events among patients a Metaanalysis Statintreated [ J ]. Circulation ,2013,128 ( 14 ) : 1504-1512.
